Plasmatology
Scope & Guideline
Elevating the Discourse in Hematology
Introduction
Aims and Scopes
- Biochemical Characterization:
Research focused on the biochemical properties and functional characteristics of plasma components, including growth factors, anticoagulants, and other proteins. - Clinical Applications:
Studies addressing the clinical use of plasma products in treating various conditions, including hematological diseases, immune disorders, and complications arising from treatments. - Innovative Therapeutic Strategies:
Exploration of new therapeutic approaches utilizing plasma, such as CRISPR technologies, plasma exchange techniques, and novel purification processes. - Public Health and Policy Insights:
Research evaluating the implications of plasma management in healthcare settings, including blood product utilization, health equity, and access to therapies. - Case Studies and Retrospective Analyses:
Detailed examinations of specific clinical cases or retrospective studies that provide insights into the effectiveness and challenges associated with plasma therapies.
Trending and Emerging
- Genetic and Molecular Approaches:
An increasing focus on genetic analysis and molecular mechanisms, such as CRISPR and other gene-editing technologies, showcases the integration of cutting-edge science into plasma therapy. - COVID-19 Related Research:
A significant rise in studies related to COVID-19, particularly the therapeutic use of convalescent plasma and vaccine-related antibody responses, reflects the pandemic's influence on plasma research. - Patient-Centric Studies:
A trend towards research that emphasizes patient outcomes, quality of life, and health equity indicates a growing recognition of the importance of patient perspectives in plasma-related therapies. - Interventional Studies:
There is a notable increase in clinical trials and interventional studies assessing the efficacy of plasma therapies for various diseases, highlighting a shift towards evidence-based practice in plasma medicine. - Public Health and Resource Management:
Emerging themes around the management of plasma resources, including ethical considerations and policy implications, suggest a growing emphasis on the systemic aspects of plasma utilization in healthcare.
Declining or Waning
- Historical Case Reports:
There has been a noticeable decrease in the publication of traditional case reports, as the journal appears to be focusing more on innovative research and broader clinical implications rather than isolated clinical narratives. - Basic Science Studies:
Research that delves into the fundamental science of plasma components without direct clinical application seems to be waning, possibly due to a preference for studies that bridge the gap between bench and bedside. - Exploratory Studies on Rare Conditions:
Investigations into less common plasma-related conditions or niche therapeutic applications are becoming less frequent, indicating a potential shift towards more prevalent clinical issues.
Similar Journals
Transfusionsmedizin
Uniting expertise to improve blood transfusion safety and efficacy.Transfusionsmedizin is a premier journal dedicated to the field of transfusion medicine, published by the renowned GEORG THIEME VERLAG KG. With an ISSN of 2191-8805 and an E-ISSN of 2191-8813, this journal serves as a vital platform for disseminating cutting-edge research and clinical advancements in blood transfusion practices. Although it operates under a subscription model, the journal is committed to high-quality peer-reviewed content that addresses contemporary challenges and innovations in transfusion therapy. By fostering dialogue among researchers, clinicians, and students, Transfusionsmedizin aims to advance patient care and enhance the safety and efficacy of transfusion practices globally. Its contributions are essential for professionals engaged in transfusion science, hematology, and related medical fields, solidifying its reputation as a critical resource for staying abreast of the latest developments in transfusion research.
Turkish Journal of Hematology
Pioneering insights into blood disorders and treatments.Turkish Journal of Hematology is an esteemed publication dedicated to advancing the field of hematology, producing influential research since its inception in 1999 under the auspices of GALENOS PUBL HOUSE. With an Open Access model, it facilitates widespread dissemination of knowledge, allowing researchers, clinicians, and students to stay abreast of the latest developments in blood disorders and treatments. With an ISSN of 1300-7777 and an E-ISSN of 1308-5263, the journal holds a commendable position in the academic community, evidenced by its 2023 Q3 ranking within the hematology category and its standing at #80 out of 137 in the Scopus database, placing it in the 41st percentile. Covering a wide scope of topics within hematology, this journal serves as a critical resource for disseminating innovative research and clinical practices pertinent to the ongoing challenges faced in this vital area of medicine. With its continuous publication until 2024, Turkish Journal of Hematology remains a beacon for enhancing the understanding and treatment of hematological conditions within the Turkish and global medical communities.
Plasma Processes and Polymers
Transforming Ideas into Impactful Solutions in Polymer SciencePlasma Processes and Polymers is a leading peer-reviewed journal published by WILEY-V C H VERLAG GMBH, focusing on the innovative field of plasma science and polymer technology since its inception in 2004. With an ISSN of 1612-8850 and an E-ISSN of 1612-8869, this journal has established its reputation within the scientific community, holding a commendable Q2 ranking in both Condensed Matter Physics and Polymers and Plastics for 2023. Recognized for its rigorous standards and impactful contributions to the field, it ranks in the top 20% of the Physics and Astronomy category and top 26% of the Materials Science category, as per Scopus metrics. Catering to researchers, professionals, and students alike, the journal publishes cutting-edge articles that advance understanding and application of plasma processes in polymer science, thereby bridging theoretical insights with practical implications. While currently not offering open access, it provides a critical platform for advancing knowledge and fostering innovation, making it essential reading for those at the forefront of polymer research and applications.
CONTRIBUTIONS TO PLASMA PHYSICS
Elevating Knowledge in Plasma Physics Since 1988CONTRIBUTIONS TO PLASMA PHYSICS is a distinguished journal dedicated to advancing the field of plasma physics, published by WILEY-V C H VERLAG GMBH. Since its inception in 1988, this journal has provided a platform for high-quality research, fostering collaboration and dissemination of knowledge in the condensed matter physics domain. With its current ranking of Q3 in the 2023 assessments, the journal is recognized for its contributions to the discipline, as indicated by its position in the Scopus rankings (Rank #252/434) and 42nd percentile within its category. Researchers and professionals engaged in plasma physics are encouraged to submit their work, as the journal aims to publish innovative studies that push the boundaries of current understanding and application in plasma phenomena. While currently not offering open access, the journal remains a vital resource for insights into the complexities and advancements in plasma research, operating from its base in Germany.
JOURNAL OF CLINICAL APHERESIS
Elevating Clinical Outcomes: The Apheresis Research HubJOURNAL OF CLINICAL APHERESIS, published by WILEY, serves as a premier platform for disseminating cutting-edge research in the specialized field of apheresis and its clinical applications. Established in 1982, this journal has been a vital resource for healthcare professionals, researchers, and students, focusing on innovative techniques, advancements in clinical practices, and the therapeutic use of apheresis in hematology and other medical disciplines. With an ISSN of 0733-2459 and E-ISSN 1098-1101, the journal is indexed in various databases, reflecting its solid academic reputation. Currently positioned in the Q3 quartile rankings for both Hematology and Miscellaneous Medicine categories, it offers insightful views into evolving methodologies and case studies that significantly impact patient care. Despite not being open access, the journal remains highly regarded within its community, ensuring that essential findings reach those dedicated to improving clinical outcomes in apheresis practices. Researchers and healthcare professionals are encouraged to engage with its comprehensive studies and foster further advancements in the field.
VOX SANGUINIS
Advancing Hematology Through Innovative ResearchVOX SANGUINIS is a distinguished peer-reviewed journal in the fields of Hematology and Medicine, published by Wiley, a leading academic publisher based in the United Kingdom. With a rich history dating back to its inception in 1952, this journal has consistently provided a platform for innovative research and insightful reviews, advancing the understanding of blood-related disorders and therapies. As evidenced by its robust performance—ranking #57 out of 137 in Scopus for Medicine in Hematology and holding a Q2 classification in both Hematology and miscellaneous Medicine categories—VOX SANGUINIS is recognized for its significant contributions to the scientific community. This journal serves as a vital resource for researchers, professionals, and students alike, fostering knowledge exchange and collaboration within the field. With its ongoing commitment to quality and integrity, VOX SANGUINIS continues to shape the future of hematological research well into 2024 and beyond.
Plasma is a leading open-access journal published by MDPI, devoted to the exploration and advancement of knowledge in the fields of engineering, physics, and materials science. Established in 2018, this journal provides a vital platform for researchers, professionals, and students to disseminate original findings and critical reviews related to plasma science, its applications, and its interdisciplinary aspects. With an E-ISSN of 2571-6182, Plasma actively promotes open access to ensure that research is widely accessible, reinforcing its commitment to accelerating scientific communication and collaboration across global communities. The journal enjoys respectable rankings in Scopus, with a notable position in Engineering, Physics and Astronomy, and Materials Science categories, making it an essential resource for those seeking to remain at the forefront of plasma research. Covering a range of topics until 2024, Plasma invites cutting-edge contributions that push the boundaries of understanding in this dynamic field.
Turkish Journal of Plastic Surgery
Connecting Research with Clinical ExcellenceTurkish Journal of Plastic Surgery, published by WOLTERS KLUWER MEDKNOW PUBLICATIONS, serves as a pivotal platform for the dissemination of innovative research and clinical findings within the dynamic field of plastic surgery. With an ISSN of 1300-6878 and an E-ISSN of 2528-8644, this Open Access journal has been committed to making high-quality research accessible since 2018, fostering a broader reach and engagement among healthcare professionals, researchers, and students alike. Although its Scopus coverage has been discontinued since 2015, the journal maintains relevance via its niche in Medicine - Surgery, where it ranks 337 out of 422, placing it in the 20th percentile. Addressing a spectrum of topics from reconstructive techniques to aesthetic advancements, the Turkish Journal of Plastic Surgery not only contributes to the academic body of knowledge but also provides practical insights for clinical practices, thereby enhancing patient outcomes in the realm of plastic surgery.
Egyptian Journal of Haematology
Pioneering Knowledge in Hematologic Malignancies and CareThe Egyptian Journal of Haematology, published by WOLTERS KLUWER MEDKNOW PUBLICATIONS, stands as a pivotal resource in the field of hematology, particularly within the context of Egypt and the broader Middle Eastern region. This journal is dedicated to disseminating high-quality research that explores the latest advancements in blood disorders, hematologic malignancies, and transfusion medicine. With a focus on original research, case studies, and reviews, it aims to provide a comprehensive platform for hematologists, researchers, and healthcare professionals to enhance their understanding and management of hematological conditions. Although it is not an open-access journal, the rigorous peer-review process ensures that only the most impactful studies are published, contributing to the journal's reputation in the academic community. The Egyptian Journal of Haematology serves as an essential tool for advancing knowledge, improving clinical outcomes, and fostering collaboration among experts in the field.
Hematology-American Society of Hematology Education Program
Navigating the Future of Hematology TogetherHematology-American Society of Hematology Education Program is a premier peer-reviewed journal dedicated to advancing the field of hematology through comprehensive educational content. Published by the American Society of Hematology, this journal plays a crucial role in disseminating knowledge to researchers, clinicians, and students in hematology and related disciplines. With an impressive Q1 status in the field, it ranks among the top journals at the forefront of hematological research, as evidenced by its 60th percentile ranking in Scopus' Medicine - Hematology category. Although it does not offer open access, the journal provides invaluable insights and educational resources from leading experts, focusing on the latest advancements, treatment protocols, and evolving understanding of blood disorders. Covering a wide range of topics, from basic research to clinical applications, this journal is essential for anyone seeking to deepen their expertise and stay informed on the latest developments in hematology. For further engagement, readers can access insightful articles published since 2001, ensuring a rich repository of knowledge for ongoing research and clinical excellence.